NCT01209793View on ClinicalTrials.gov

Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy
Interventions
BIOLOGICAL

REGN846

5 IV cohorts (Dose 1, 2, 3, 4, 5)

Trial Locations (1)

Unknown

Nucleus Network, Melbourne

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01209793 - Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers | Biotech Hunter | Biotech Hunter